Late complications after radiotherapy for prostate cancer

被引:4
|
作者
Jung, H. [1 ,2 ]
Beck-Bornholdt, H. -P. [2 ]
Svoboda, V. [2 ,4 ]
Alberti, W.
Herrmann, T. [3 ]
机构
[1] Univ Hosp Hamburg Eppendorf, Dept Radiotherapy & Radiooncol, Lab Radiobiol & Expt Radiooncol, D-20246 Hamburg, Germany
[2] Univ Hosp Hamburg Eppendorf, Inst Biophys & Radiobiol, D-20246 Hamburg, Germany
[3] Tech Univ Dresden, Dept Radiotherapy & Radiooncol, Dresden, Germany
[4] St Marys Hosp, Dept Radiotherapy, Dept Clin Oncol, Portsmouth Oncol Ctr, Portsmouth PO3 6AQ, Hants, England
关键词
Late effects; Complications; Radiotherapy; Prostate cancer; Kinetics of late effects; LATE RECTAL TOXICITY; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY;
D O I
10.1007/s00066-012-0142-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to analyze in detail the time course of the incidence of radiation-induced late effects. For this purpose, unpublished data of patients treated by radiation therapy in Hamburg in the late 1980s were analyzed. Relatively large volumes were exposed to comparatively high doses, thus leading to a high rate of treatment-related side effects. A total of 180 consecutive patients received radiotherapy for prostate cancer. The median age was 66 years (range 41-88 years). The median of the maximum dose was 77.5 Gy (range 56.3-95 Gy) and overall treatment time was 51 days (range 28-128 days). Endpoints analyzed were late complications of grade 3 or higher, overall and disease-free survival, local tumor control, and distant metastases. Data analysis was actuarial and the log-rank test was used to compare the various subgroups. After 2 years, 80.5 +/- 3.2% of the patients were without any complications of grade 3 or higher, and after 5 years a constant level of 70.3 +/- 4.0% was approached. When multiple lesions occurred per patient, the later events were disregarded. A total of 66 complications occurred in 42 patients. The percentage of patients being free from late complications, plotted as a function of time after start of radiation therapy, was adequately described by an exponential function and a constant fraction. Complications approached a constant level of 70.3% at a rate of 5.3% per month. This means that patients who will develop a complication do so at exponential kinetics and at a relatively high rate, whereas about 70% of the patients will never experience a late effect even over long observation periods. After subdividing the maximum dose into three equal dose groups of 55 patients each (< 73.3 Gy, 73.3-80 Gy, > 80 Gy), the constant fraction decreased from 85.7 to 72.8% and 52.2%, whereas the incidence rate was 4.3%, 7.7%, and 5.6% per month and, thus, almost independent of radiation dose. For a given group of patients, the rate of the incidence of late complications appears to be independent of radiation dose and (from analyzing data in the literature) independent of the grade of lesions, whereas the fraction of patients without late effects depends on both parameters.
引用
收藏
页码:965 / 974
页数:10
相关论文
共 50 条
  • [31] Osteosarcoma after radiotherapy for prostate cancer
    Papalas, John A.
    Wylie, John D.
    Vollmer, Robin T.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2011, 15 (03) : 194 - 197
  • [32] Surveillance after prostate cancer radiotherapy
    Supiot, S.
    Rio, E.
    Clement-Colmou, K.
    Bouchot, O.
    Rigaud, J.
    CANCER RADIOTHERAPIE, 2011, 15 (6-7): : 540 - 545
  • [33] Cancer Control and Complications of Salvage Local Therapy After Failure of Radiotherapy for Prostate Cancer: A Systematic Review
    Parekh, Arti
    Graham, Powell L.
    Nguyen, Paul L.
    SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (03) : 222 - 234
  • [34] Assessment of late morbidity after 3D conformal radiotherapy for prostate cancer
    Alco, G.
    Igdem, S.
    Ercan, T.
    Turkan, S.
    Okkan, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 241 - 241
  • [35] Late morbidity and oncological outcome after radical hypofractionated radiotherapy in men with prostate cancer
    Di Staso, Mario
    Bonfili, Pierluigi
    Gravina, Giovanni L.
    Pagliuca, Milena Di Genesio
    Franzese, Pietro
    Buonopane, Sergio
    Osti, Mattia F.
    Valeriani, Maurizio
    Festuccia, Claudio
    Enrici, Riccardo Maurizi
    Tombolini, Vincenzo
    BJU INTERNATIONAL, 2010, 106 (10) : 1458 - 1462
  • [36] Factors influencing late rectal toxicity after radiotherapy of localized prostate cancer.
    Lim, G
    Lau, H
    Brar, S
    Angyalfi, S
    Balogh, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 435S - 435S
  • [37] Predictors of severe late urinary toxicity after curative radiotherapy for localised prostate cancer
    Takeda, K.
    Takayama, Y.
    Kadoya, N.
    Takagi, H.
    Ito, K.
    Chiba, T.
    Sato, K.
    Dobashi, S.
    Umezawa, R.
    Yamamoto, T.
    Ishikawa, Y.
    Takeda, K.
    Matsushita, H.
    Kawasaki, Y.
    Mitsuduka, K.
    Jingu, K.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S823 - S824
  • [38] Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer
    Peeters, S
    Lebesque, J
    Heemsbergen, W
    van Putten, W
    Slot, A
    Dielwart, M
    Koper, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S125 - S126
  • [39] Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer
    Peeters, STH
    Lebesque, JV
    Heemsbergen, WD
    van Putten, WLJ
    Slot, A
    Dielwart, MFH
    Koper, PCM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (04): : 1151 - 1161
  • [40] LATE MORBIDITY AND ONCOLOGICAL OUTCOME AFTER RADICAL HYPOFRACTIONATED RADIOTHERAPY IN MEN WITH PROSTATE CANCER
    Di Staso, M.
    Bonfili, P.
    Gravina, G. L.
    Paqliuca, M. Di Genesio
    Franzese, P.
    Limoncin, E.
    Osti, M. F.
    Buonopane, S.
    Valeriani, M.
    Riccardo, M. E.
    Tombolini, V.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S408 - S408